2014 annual financial data
Celldex Therapeutics 2014 Operating cash flow margin
Direct answer
Operating cash flow margin was -2,831.48%.
Operating income was -122,430,000 USD and net income was -118,080,000 USD.
Operating cash flow was -101,537,000 USD.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,586,000 USD
- Operating income
- -122,430,000 USD
- Net income
- -118,080,000 USD
- Operating cash flow
- -101,537,000 USD